Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Haematologica|December 4, 2025
Unemployment in patients with histiocytic neoplasms is frequent and associated with clinical and treatment characteristicsAnne S Reiner, Dana Bossert, Allison M Sigler, et al.
Molecular Cancer Therapeutics|April 25, 2019
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell HistiocytosisFilip Janku, Eli L Diamond, Aaron M Goodman, et al.
International Journal of Molecular Sciences|October 28, 2023
Erdheim-Chester Disease Due to a Novel Internal Duplication of NRAS: Response to Targeted Therapy with CobimetinibJosé A Riancho, José L Hernández, Carmen González-Vela, et al.
Ophthalmology. Retina|June 8, 2021
Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated RetinopathyJasmine H Francis, Julia Canestraro, Dianna Haggag-Lindgren, et al.
Blood|March 7, 2025
Long-term outcomes with single-agent BRAF inhibitor therapy in Erdheim-Chester diseaseGaurav Goyal, Anne S Reiner, Dana Bossert, et al.
Journal of Neuro-Oncology|April 19, 2022
Coping with glioblastoma: prognostic communication and prognostic understanding among patients with recurrent glioblastoma, caregivers, and oncologistsLeah E Walsh, Laura C Polacek, Katherine Panageas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 2, 2017
The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohortNeval Ozkaya, Marc K Rosenblum, Benjamin H Durham, et al.
Leukemia & Lymphoma|February 25, 2020
The unique burden of rare cancer caregiving: caregivers of patients with Erdheim-Chester diseaseAllison J Applebaum, Laura C Polacek, Leah Walsh, et al.
Blood Advances|March 1, 2023
Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysisAshley Aaroe, Razelle Kurzrock, Gaurav Goyal, et al.
Pediatric Blood & Cancer|July 28, 2017
Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosisSara Zarnegar, Benjamin H Durham, Pallavi Khattar, et al.
Pageof 13